AMGEN HIGHLIGHTS HEMATOLOGY PORTFOLIO AT ASH 2023
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
RBC Capital upgrades Amgen (AMGN) on 'improving position of stability' and diminishing uncertainty
December 12, 2023 8:44 AM ESTRBC Capital lifted its rating for Amgen (NASDAQ: AMGN) to Outperform from Sector Perform in a note Tuesday, raising the price target to $300 from $256 per share.
Analyst Gregory Renza said the company's pipeline optionality, as well as its 2024 catalyst setup, positions it... More
